Imperial Wins International Creative Awards. Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies
  • About
    • News
    • Corporate Responsibility
  • Contact
    • Career Opportunities
    • Contact Imperial
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies
  • About
    • News
    • Corporate Responsibility
  • Contact
    • Career Opportunities
    • Contact Imperial
  • Blog
  • Marketplace
Category:

Life-Science Events

    Life-Science EventsPatient Recruitment and Retention

    SCOPE Summit: Clinical Trials Industry is Rejuvenated and Ready

    by William McEwen February 20, 2023
    written by William McEwen

    Imperial’s team attended the annual SCOPE Summit in Orlando, where they spoke with hundreds of clinical trials industry colleagues and attended talks and workshops.

    In this post, Imperial team members Dan McDonald, Imogen Cheese, and Ted Corrigan tell us what they found noteworthy at SCOPE.

    The Clinical Trials Industry is Thriving Post-COVID

    Dan McDonald told us attendance had clearly increased since last year. “An obvious indicator was the size and layout of the space needed for the opening night cocktail reception,” he said. “It was double the size of last year and full. The industry is definitely 100 percent back out there. This includes the sponsor companies, who were the last to lift travel restrictions on their teams. All the major players were there, plus many fledgling companies and newer entries into the market.”

    Diversity

    Dan said recruitment was again in the spotlight, with diversity as the primary area of focus for the clinical trials industry. “The need to enroll diverse patient populations has seemed to give patient recruitment firms a new lease on life while also providing an entry point for decentralized trials and other novel companies,” he said. Dan singled out two companies doing important work: Javara, which provides clinical research infrastructure and operations for community health networks that support diverse and underserved patient populations, and Emvenio, which brings trials to patients via mobile and telehealth technology.

    Hybrid Trial Design

    Imogen Cheese said one of SCOPE’s hot topics was hybrid trial design. “A new type of decentralized trial is evolving,” she said, “and along with it, the importance to fully utilize equipment and resources in a unique way – taking it to the patients or tailoring it to minimize the patient burden.”

    One of Imogen’s favorite sessions at SCOPE was presented by Caroline Jackson of mdgroup, who shared information from a Phase 1 study in a rare disease model. “The study team had tests and centrifuges taking place in participants’ homes. It was groundbreaking, a true look into the future of trials,” Imogen said. (Dan interviewed Caroline along with Mary Jo Lamberti of Tufts Center for the Study of Drug Development and Rick O’Hara of Endo Pharmaceuticals for his Executive Interview Series; see what they had to say below.)

    Technology in the Driver’s Seat

    A recurring theme at SCOPE was the latest tools technology brings to the clinical trials industry. Ted Corrigan was interested to see how decentralized trials were evolving. “Thanks to technology, conducting trials where the patient wants is a reality. The patient-centric focus is coming to life as patients are opting to conduct trial activities where they feel the most comfortable: from the patient’s home to their doctor’s office, local hospital, pharmacy, and even the grocery store,” he said. “The patient may have many different reasons to choose a location simply based on the therapy, their age, space available for testing equipment, and travel preferences. This evolution was on full display at SCOPE.”

    Imogen watched a demo of Medable’s novel e-consent solution. ‘It was enlightening to see how far the technology has come and to learn that the industry, at last, is adopting this approach to patient education and consent,” she said. “The ability to weave in the normal black and white content of an ICF, and rich media, along with links to other tools and resources, illustrations, guides, with save and return features, shows us the future is bright for efficiency, proper consent, and reconsent.”

    Patient-Focus

    Imogen was impressed with one of Pfizer’s recent awareness and engagement initiatives. The company sent a gift to every patient that participated in its Covid vaccine clinical trials—a card, a certificate, and a medal. Pfizer received an honorary mention at the SCOPE awards ceremony for this initiative. “This was a sizeable expense, and it represents a dedicated investment in making participants feel appreciated,” Imogen said. “It is important to thank the patients who participate in clinical trials, yet it doesn’t always happen.”

    Imogen added: “The groundbreaking nature of studies conducted during the Covid pandemic and lockdowns reinforced to all in our industry that there are patients out there who want to take part in trials. Finding them, keeping them engaged, and thanking them afterward is every bit as important as the more routine or mundane elements of the trial, such as data collection.”

    Imperial Advantage

    The team reports that SCOPE attendees expressed interest in Imperial’s trial support services, including study and site print materials and translations. They were also eager to discuss how Imperial’s overall linear solution could make a difference in the many areas where they are struggling. There was much interest in Imperial’s streamlined approach and how it can drive down costs and improve time efficiencies.

    Imogen said, “Many sponsors and CROs have been using the same vendors for three to four years, especially through the Covid lockdowns. They now realize that the solution they have isn’t working in today’s changing, fast-paced, hybrid style of trial delivery.”

    If you didn’t get a chance to see us at SCOPE, now is a great time to get in touch. Contact us to talk about how the Imperial single workstream can lighten your load, how printed materials can streamline your study, and how our logistics team will get your materials to their global destinations.

    February 20, 2023 0 comment
    0 FacebookTwitterLinkedinEmail
  • Business InsightsLife-Science EventsPatient EngagementPatient Recruitment and Retention

    Summit Reveals Clinical Trial Challenges and Solutions

    by Imogen Cheese December 1, 2022
    by Imogen Cheese December 1, 2022

    My colleague Frances Bentley and I had the privilege of attending the 8th Annual Clinical Monitoring and Patient Recruitment Retention (CMPRR) Summit in Barcelona. Several clinical trial challenges and solutions were discussed. I was there to present a talk titled “Exploring the Hidden Challenges to…

    1 FacebookTwitterLinkedinEmail
  • Business InsightsLife-Science EventsPatient Engagement

    Opening Day at DIA Meeting: Two Clinical Trial Approaches Join Forces

    by Dan McDonald June 21, 2022
    by Dan McDonald June 21, 2022

    Hello from the 2022 DIA Global Annual Meeting. Not surprisingly, decentralized clinical trial approaches has the spotlight here. This includes: Wearables and sensors for remote data collection Mobile screening units Home trial visits Also in the spotlight at the DIA meeting is the rise of…

    1 FacebookTwitterLinkedinEmail
  • Business InsightsLife-Science EventsPatient Recruitment and Retention

    OCT East: Industry Agility and Decentralized Clinical Trials

    by Dan McDonald June 1, 2022
    by Dan McDonald June 1, 2022

    Sponsors, CROs, and vendors gathered in person at the Outsourcing in Clinical Trials (OCT) East Coast Summit in King of Prussia, Pennsylvania, over two days in May. Speakers discussed the journey of recent years and shared predictions of what the future holds for new strategies.…

    1 FacebookTwitterLinkedinEmail
  • Business InsightsLife-Science Events

    Fresh Initiatives Revealed for Clinical Studies

    by Imogen Cheese May 24, 2022
    by Imogen Cheese May 24, 2022

    The Outsourcing In Clinical Trials (OCT) Europe conference held in Barcelona was fully face-to-face. No prerecorded talks! A conference hall heavy with exhibitors for clinical studies. With hundreds of delegates walking around laughing and chatting, all enjoying the return to business as usual! In-person conferences…

    2 FacebookTwitterLinkedinEmail
  • Life-Science EventsPatient EngagementPatient Recruitment and Retention

    Patient Engagement in the Evolving World of Clinical Trials

    by Imogen Cheese March 23, 2022
    by Imogen Cheese March 23, 2022

    I was delighted to speak at the 2022 KPM Morgan Operational Excellence in Clinical Trials (OECT) Summit in Berlin. My topic was one I am passionate about – patient engagement. I was happy to see others speak about this important subject, too. Industry Voices on…

    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    Diversity Takes Center Stage at SCOPE 22

    by Dan McDonald March 1, 2022
    by Dan McDonald March 1, 2022

    Diversity in clinical trial participation emerged as one of the most important and impassioned topics presented and discussed during the SCOPE 22 Summit in Orlando, Florida. Covid, and its wide-ranging impact, served to reveal how different groups were differently affected, and it shed light on…

    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    Getting Back Out There: SCOPE 22 Summit Unites Colleagues

    by Imogen Cheese February 24, 2022
    by Imogen Cheese February 24, 2022

    Shhh! Don’t tell anyone, but work conferences are about more than clients! After spending most of 2021 desperately waiting for conferences to start up again and work travel to return, the SCOPE 22 Summit appeared with a whirl of activity. It came as a shock…

    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    Patient Recruitment Changes Revealed as Trials Industry Reunites

    by Imogen Cheese December 16, 2021
    by Imogen Cheese December 16, 2021

    When you’ve had to wait 20 months to travel for work, you hold that first re-emergence into pre-pandemic day-to-day business activity on a high pedestal. Expectations are HIGH, and a quest for perfection sways with the giddy anticipation that once again you are actually getting…

    0 FacebookTwitterLinkedinEmail
  • Life-Science Events

    Clinical Trial Conference Offers New Solutions

    by Dave Woodard December 7, 2021
    by Dave Woodard December 7, 2021

    I recently attended OCT New England, which was my first in-person clinical trial conference since the spring of 2020! It felt great to be with so many people from the industry. Pandemic precautions were very much in place, with required Covid screenings and masks. I…

    0 FacebookTwitterLinkedinEmail
  • 1
  • 2
  • 3
  • …
  • 5

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 2

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 3

    See Do Get

    August 12, 2014
  • 4

    Clinical Trial Supply Chains: The Key to Avoiding Disruptions

    May 10, 2022
  • 5

    COVID-19 Brings Pressure Testing to Ancillary Supplies and Equipment

    May 4, 2021

Categories

  • Ancillary Trial Supplies and Equipment (14)
  • Business Insights (102)
  • Clinical Trial Writing and Design (20)
  • Life-Science Events (43)
  • Patient Engagement (14)
  • Patient Recruitment and Retention (75)
  • Site Materials & Logistics (30)
  • Study Site Management (18)
  • Translation of Study Materials (16)
  • Uncategorized (1)
Imperial Clinical Research Services Blog

Imperial CRS is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

© Imperial CRS, Inc. | Privacy Policy